Plantarc Bio Ltd. Logo

Plantarc Bio Ltd.

Developing high-yield, resilient crops via gene discovery for global seed companies.

PLNT | TA

Overview

Corporate Details

ISIN(s):
IL0011714040
LEI:
Country:
Israel
Address:
Birkat Am St 61-63, 4390500 Giv’at Hen
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Plantarc Bio Ltd. is an agricultural biotechnology company focused on enhancing global food security through genetic technology. The company specializes in gene discovery and the development of RNAi-based products to improve crop performance and sustainability. It utilizes its proprietary Direct-In-Plant (DIP™) platform for gene discovery and the DIPPER™ platform for gene-editing optimization. Plantarc Bio's key development areas include increasing crop yield, improving drought resistance, and creating herbicide and insect tolerance. The company collaborates with global seed companies to develop and commercialize enhanced traits for major crops such as soybeans, canola, rice, and sugarcane.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2023-03-14 11:09
Investor Presentation
Presentation-World Agri-Tech Innovation Summit
English 9.4 MB
2023-03-14 11:09
Regulatory News Service
Presentation-World Agri-Tech Innovation Summit
Russian 43.3 KB
2022-01-27 14:21
Regulatory News Service
Plantarc – Appointment of a Market Maker, will not be included in the illiquid …
Hebrew (modern) 256.9 KB
2021-01-06 15:29
Regulatory News Service
On Thursday, 7 January 2021, trading will commence in the following Security: P…
Hebrew (modern) 174.5 KB
2021-01-04 17:13
Regulatory News Service
Identifying Details of New Security -PLANT ARC, PLANT ARC W1
Hebrew (modern) 178.5 KB
2020-11-18 16:16
Investor Presentation
Investor Presentation
English 1.8 MB
2020-11-18 16:16
Pre-Annual General Meeting Information
Investor Presentation
Russian 42.7 KB

Automate Your Workflow. Get a real-time feed of all Plantarc Bio Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Plantarc Bio Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Plantarc Bio Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Isofol Medical Logo
Developing a drug to enhance chemotherapy efficacy for solid tumors like colorectal cancer.
Sweden ISOFOL
B2B platform for Ukraine-Korea trade, investment, and post-war reconstruction.
South Korea 052770
IVISIONWORKS CO.,LTD. Logo
Accelerates social impact startups & develops digital therapeutics for cognitive rehabilitation.
South Korea 469750
A diversified, Asia-focused conglomerate with businesses in property, retail, auto, and more.
Bermuda N/A
The world's largest uranium producer, managing the front-end of the global nuclear fuel cycle.
Kazakhstan N/A
KAINOS MEDICINE, INC. Logo
Develops small molecule drugs for neurodegenerative diseases, cancers, and infectious diseases.
South Korea 284620
Kanamoto Co., Ltd. Logo
Global provider of rental construction equipment, also selling used machinery and steel products.
Japan 9678
Keihan Holdings Co.,Ltd. Logo
A conglomerate integrating transport, real estate, and retail for regional development.
Japan 9045
KNT-CT Holdings Co.,Ltd. Logo
A travel holding company offering themed tours and corporate travel solutions to boost Japan tourism.
Japan 9726
KoBioLabs, Inc. Logo
Develops AI-driven microbiome therapeutics for immune, metabolic, and brain disorders.
South Korea 348150

Talk to a Data Expert

Have a question? We'll get back to you promptly.